1
|
Beresniak A, Schmidt A, Proeve J, Bolanos E, Patel N, Ammour N, Sundgren M, Ericson M, De Moor G, Kalra D, Dupont D. Cost-Benefit Assessment of the Electronic Health Records for Clinical Research (EHR4CR) European Project. Value Health 2014; 17:A630. [PMID: 27202235 DOI: 10.1016/j.jval.2014.08.2251] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- A Beresniak
- Data Mining International, Geneva, Switzerland
| | - A Schmidt
- F Hoffmann-La Roche Ltd, Basel, Switzerland
| | - J Proeve
- Bayer Healthcare, Leverkusen, Germany
| | - E Bolanos
- Eli Lilly and Company, Alcobendas, Spain
| | - N Patel
- Eli Lilly and Company (until December 2013), Windlesham, Surrey, UK
| | - N Ammour
- Sanofi-Aventis R&D, Chilly-Mazarin, France
| | | | | | | | - D Kalra
- The European Institute for Health Records (EuroRec), London, UK
| | - D Dupont
- Data Mining International, Geneva, Switzerland
| |
Collapse
|